The combination of mobile connectivity, software and medicine could revolutionize healthcare, and many mobile and IT giants are investing heavily in it. One of these, of course, is Google parent Alphabet, which has a division devoted to the topic, Verily Life Sciences. This has announced a joint venture with French pharmaceutical firm Sanofi to address diabetes, one of the developed world’s biggest health problems. The two companies will invest about $500m in the JV, which is called Onduo, and look to innovate in the way diabetes is monitored and treated. Already partners, they will now have greater resources to combine their respective capabilities – Sanofi’s in drugs and Verily’s in miniaturized connected devices, software and analytics. The venture will focus…